Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

AnaptysBio Inc sell JPMorgan Chase & Co.

AnaptysBio Inc
Start price
€19.70
13.04.23 / 50%
Target price
€28.05
13.04.24
Performance (%)
1.02%
End price
€19.90
14.04.24
Summary
This prediction ended on 14.04.24 with a price of €19.90. With a performance of 1.02%, the SELL prediction by JPMorgan_Chase___Co_ for AnaptysBio Inc was trending in the wrong direction JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
AnaptysBio Inc 6.557% 6.557% 3.723%
iShares Core DAX® 0.961% -2.210% 12.839%
iShares Nasdaq 100 2.626% -1.918% 38.498%
iShares Nikkei 225® 0.217% -7.216% 19.425%
iShares S&P 500 1.540% -1.858% 27.801%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread AnaptysBio Inc diskutieren
Prediction Sell
Perf. (%) 1.02%
Target price 28.052
Change
Ends at 13.04.24

AnaptysBio, Inc. (NASDAQ: ANAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $31.00. They now have an "underweight" rating on the stock.
Ratings data for ANAB provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
13.04.23
In the thread Trading AnaptysBio Inc
Prediction Sell
Perf. (%) 1.02%
Target price 28.052
Change
Ends at 13.04.24

Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten

JPMorgan Chase & Co. 
0
Report Share
14.04.24